Back to Search
Start Over
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
- Source :
- Urologic Clinics of North America. 50:109-114
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
-
Abstract
- Liquid biopsies such as circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have great potential to serve as prognostic and predictive biomarkers in urologic cancers. The possibility of using liquid biopsies for real-time noninvasive and dynamic monitoring of response to therapy has been an active area of investigation. In this brief review, we outline the evidence for the potential clinical utility of CTC and ctDNA analyses in prostate, urothelial, and renal cancers.
Details
- ISSN :
- 00940143
- Volume :
- 50
- Database :
- OpenAIRE
- Journal :
- Urologic Clinics of North America
- Accession number :
- edsair.doi.dedup.....a452d9749992f81fd4a2b30423d4d3ac